CO107 Clinical Outcomes of Patients With Metastatic Renal Cell Carcinoma (MRCC) With or Without Sarcomatoid Differentiation Treated With Systemic Therapy in Real-World Canadian Setting

Autor: G Bou-Nehme Sawaya, A Dragomir, C Kollmannsberger, NS Basappa, A Kapoor, D Soulières, A Finelli, DYC Heng, L Wood, V Castonguay, C Canil, E Winquist, J Graham, GA Bjarnason, B Bhindi, AK Lalani, F Pouliot, RH Breau, S Tanguay

Publikováno v: Value in Health. 25:S39

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa58839beeec2c8d9de1fd704d180864
https://doi.org/10.1016/j.jval.2022.09.186

Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality.

Autor: Robert A; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Mallick R; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., McIsaac DI; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Department of Anesthesiology and Pain Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, Ontario, Canada., Lavallée LT; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Division of Urology, University of Ottawa, Ottawa, Ontario, Canada., Bhindi B; Division of Urology, University of Calgary, Calgary, Alberta, Canada., Heng D; Division of Medical Oncology, University of Calgary, Calgary, Alberta, Canada., Wood LA; Division of Medical Oncology, QEII Health Sciences Center, Halifax, Nova Scotia, Canada., Rendon R; Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada., Tanguay S; Division of Urology, McGill University, Montreal, Quebec, Canada., Finelli A; Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Bansal RK; Division of Urology, McMaster Institute of Urology, McMaster University, Hamilton, Ontario, Canada., Lalani AK; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada., Basappa N; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada., Mannas MP; Urologic Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Nayak JG; Section of Urology, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; Men's Health Clinic Manitoba, Winnipeg, Manitoba, Canada., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Lattouf JB; Department of Surgery, University of Montreal, Montreal, Quebec, Canada., Pouliot F; Division of Urology, CHU of Québec and Laval University, Quebec City, Quebec, Canada., Richard PO; Division of Urology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada., Tajzler C; Ri-MUHC, McGill University, Montreal, Quebec, Canada., Breau RH; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Division of Urology, University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: The Journal of urology [J Urol] 2024 Dec 02, pp. 101097JU0000000000004348. Date of Electronic Publication: 2024 Dec 02.

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

Autor: Park CL; McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada., Moria FA; McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada., Ghosh S; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Wood L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 3A7, Canada., Bjarnason GA; Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada., Bhindi B; Southern Alberta Institute of Urology, Calgary, AB T2V 1P9, Canada., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB T2N 4N2, Canada., Castonguay V; Hotel Dieu de Quebec, Quebec, QC G1R 2J6, Canada., Pouliot F; Department of Urology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC G1V 0A6, Canada.; Department of Surgery, Université Laval, Québec, QC G1V 0A6, Canada., Kollmannsberger CK; British Columbia Cancer Agency, Vancouver, BC V5Z 3X7, Canada., Bosse D; Division of Oncology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Basappa NS; Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada., Finelli A; Princess Margaret Cancer Centre UHN, Toronto, ON M4W 1H7, Canada., Fallah-Rad N; Princess Margaret Cancer Centre UHN, Toronto, ON M4W 1H7, Canada., Breau RH; Division of Oncology, University of Ottawa, Ottawa, ON K1N 6N5, Canada., Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, ON L8S 4L8, Canada., Tanguay S; McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada., Graham J; Department of Oncology and Hematology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Saleh RR; McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Aug 18; Vol. 31 (8), pp. 4704-4712. Date of Electronic Publication: 2024 Aug 18.

Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).

Autor: Graham J; CancerCare Manitoba, Division of Medical Oncology and Hematology, University of Manitoba, Winnipeg, MB, Canada. Electronic address: jgraham9@cancercare.mb.ca., Ghosh S; Department of Medical Oncology, Faculty of Medicine and Dentistry University of Alberta, Edmonton, AB, Canada., Breau RH; Division of Urology, University of Ottawa, Ottawa, ON, Canada., Wood L; Division of Medical Oncology, QEII Health Sciences Center, Halifax, NS, Canada., Tanguay S; Department of Surgery, McGill University, Montreal, QC, Canada., Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Lalani AK; Division of Medical Oncology, McMaster University, Hamilton, ON, Canada., Bhindi B; Division of Urology, University of Calgary, Calgary, AB, Canada., Heng D; Division of Medical Oncology, University of Calgary, Calgary, AB, Canada., Finelli A; Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada., Fallah-Rad N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada., Basappa NS; Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Pouliot F; Cancer Research Center, Centre Hospitalier Universitaire de Québec - Université Laval, Québec, QC, Canada., Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102060. Date of Electronic Publication: 2024 Feb 23.

TimeTeller: A tool to probe the circadian clock as a multigene dynamical system.

Autor: Vlachou D; Mathematics Institute & Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, United Kingdom., Veretennikova M; Mathematics Institute & Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, United Kingdom., Usselmann L; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Vasilyev V; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Ott S; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Dallmann R; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Levi F; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.; Department of Statistics, University of Warwick, Coventry, United Kingdom.; UPR 'Chronotherapy, Cancer and Transplantation', Medical School, Paris-Saclay University, Medical Oncology Department, Paul Brousse Hospital, Villejuif, France., Rand DA; Mathematics Institute & Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, United Kingdom.

Publikováno v: PLoS computational biology [PLoS Comput Biol] 2024 Feb 29; Vol. 20 (2), pp. e1011779. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).